Over 14 years of research

A range of international award-winning products intended for different types of consumption and a range of consumers, produced from strains developed exclusively by the us.

Over 14 years of clinical research based on our strains thanks to the unprecedented data we collected over the years. Learn more about treatment with medical cannabis

Tikun Olam-Cannbit has extensive knowledge and experience in treating a range of medical conditions and symptoms. Our unique treatment relies on clinical research and unprecedented data collection.

About Us

Medical Cannabis Pioneers

We are proud to be the first and leading cannabis company in Israel, pioneers in clinical research and recognized as pioneers in the field of modern medical cannabis. Since 2006, we have been operating and developing in Israel and around the world.Since 2006, we have been operating and developing in Israel and around the world.

Over 14 years of experience in treating thousands of patients have led us to boast in more than 35 clinical and preclinical studies published in the world's leading scientific journals.

Rebecca was suffering from acute pain, required nursing and a wheelchair until she began treatment with Midnight strain capsules. The pain significantly decreased, she has become more independent and .

Israeli Pride: Dr. Naftali, a worldwide pioneer in researching the effects of Cannabis as treatment for Inflammatory Bowel Diseases, talks about the use of Cannabis for Crohn and Colitis.

Erez Petkevich RIP, was among the first and most loved Tikun Olam’s patients. The first strain developed by the company, Erez, is named after him.

Adiel Shalom Sabah is coping with accute Epilepsy. After many treatments have failed, causing severe side effects, Tikun Olam’s Cannabis Oil has finally made the difference and the convulsions ceased.

Questions & Answers

  • Am I eligible for a Medical Cannabis License?

    In Israel, cannabis is allowed only for few specified medical usage. However, over the years there has been growing recognition of the plant’s medical properties and its positive effect on patients, and therefore its use is permitted for medical purposes based on predefined criteria from the Ministry of Health.

    First stage – suitable diagnosis and compliance with threshold conditions

    The list of approved therapeutic indications for a license is given in Ministry of Health Procedure 106. First, you must check whether your medical condition appears on this list. The medical fields included are as follows:

    1. Oncological – cancer
    2. Neurological – Parkinson’s, Tourette syndrome, multiple sclerosis, epilepsy: adults and minors.
    3. Pain control – neuropathic pain.
    4. Infectious diseases – AIDS.
    5. Gastroenterological – Crohn’s, colitis.
    6. Psychiatric – PTSD (post-traumatic stress disorder).
    7. Palliative care – terminal patients.

    Please note that there are exceptional cases in which the use of medical cannabis may be approved for people suffering from other conditions, following application for a special permit as specified in Procedure 106.

    Once you have found a suitable indication on the list, you must check if you meet the criteria defined for that indication. The criteria mainly concern the requirement to first exhaust all conventional medication.

    You have a suitable indication + meet the threshold conditions, great!

    At this stage you are advised to seek specialist medical advice in the relevant field. The doctor can examine you and make a professional determination whether medical cannabis is suitable for you, and then we can proceed to the next stage.

    Second stage – the application:

    There are two possible routes for applying for a license:

    1. An application to the MCU (Medical Cannabis Unit) of the Ministry of Health by the specialist involved. The MCU examines every application and decides whether to approve it.

    2.  An application to an issuing doctor: there is a list of doctors in Israel who have been trained and certified by the Ministry of Health for the function of cannabis doctor. They are authorized to issue cannabis licenses without involving the Ministry of Health. List of doctors.

    Third stage – purchase the products:

    Congratulations, you have received the license and the prescriptions! Now you can purchase the medical cannabis products. Which should you buy?

    It is important to know that cannabis products are approved for use in the following forms:

    • Cannabis flowers/ rolled cannabis flowers
    • Extract (oil)
    • Cookies (for children only)

    The products are divided into categories and classified by the concentrations of the active ingredients THC and CBD they contain:

    • THC-rich cannabis products
    • Balanced cannabis products
    • CBD-rich cannabis products.

    In each group there are several categories with different concentrations.

    The different concentrations of THC and CBD – the concentration of terpenes and belonging to the indica or sativa family – these are what provide the unique therapeutic effect of each product. However, it is important to stress that there are many other variables which we take into account, such as: method of use, dose, patient’s lifestyle, other medication and background conditions.

    We think it is vital to receive personal training on correct use, and adaptation of the products for each patient according to their unique characteristics.

    If you look at your license and prescription you will find the category of products approved for you. They are shown by T/C (THC and CBD) with a number indicating the concentration.

    For example: the category 10 gram flower – T3C15 means 10 grams of the “Inflorescence” type of cannabis product in the CBD-rich group, with 3% THC and 15% CBD.

    It is important to stress that you can only purchase products your approved category/ categories.

  • מה זה תקן IMC-GMP?

  • האם מותר להמשיך את הטיפול במסגרת אשפוז בבית חולים?

  • Clinical research

     Autism or Autism Spectrum Disorder (ASD) is a developmental disorder that affects people in different ways, and no two cases are identical. Cases are more or less complex, and they are generally defined by level of functioning (open a window for further reading:) Symptoms of ASD can generally be identified at an early stage of […]

    CBD-enriched Medical Cannabis for Intractable Pediatric Epilepsy Seizure, 2016 Michal Tzadok1, Shimrit Uliel-Siboni2, Ilan Linder3, Uri Kramer2, Orna Epstein4, Shay Menascu2, Andrea Nissenkorn1, Omer Bar Yosef1, Eli Hyman4, Dorit Granot5, Michael Dor6, Tali Lerman-Sagie3, Bruria Ben-Zeev1 1Pediatric Neurology Units of Chaim Sheba Medical Center, Tel Hashomer; 2Pediatric Neurology Units of Tel Aviv Sourasky Medical Center, […]

    SAFETY AND EFFICACY OF MEDICAL CANNABIS IN FIBROMYALGIA Journal of Clinical Medicine, 2019 Iftach Sagy MD PhD1,2, Lihi Bar-Lev Schleider MA2,3, Mahmoud Abu-Shakra MD4 and Victor Novack MD PhD2 1Department of Rheumatology, Rabin Medical Center, Petach Tikva Israel; 2Cannabis Clinical Research Institute, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion University of the […]

    Prospective Analysis of Safety and Efficacy of Medical Cannabis in Large Unselected Population of Patients with Cancer European Journal of Internal Medicine, 2018 Lihi Bar-Lev Schleidera,b, Raphael Mechoulamc, Violeta Ledermanb, Mario Hiloub, Ori Lencovskya, Oded Betzalelb, Liat Shbiroa, Victor Novacka a Clinical Cannabis Research Institute, Soroka University Medical Center and Faculty of Health Sciences, Ben-Gurion […]